- Category
- Micro (2022-23)
- Udyam number
- UDYAM-WB-08-0028991

Rebrote Pharma Private Limited
About Rebrote Pharma Private Limited
Data last updated:
Rebrote Pharma Private Limited is a private limited company based in Sreebhumi, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 November 2022.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U52291WB2022PTC258188.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors including Diwakar Kumar Agrawal and Puja Kumari.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Sreebhumi, West Bengal.
Rebrote Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-08-0028991).
Company details
CIN history
Rebrote Pharma has one previous CIN (Corporate Identification Number): U24300WB2022PTC258188. The current CIN is U52291WB2022PTC258188, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U52291WB2022PTC258188 | Current |
| U24300WB2022PTC258188 | Previous |
Recognitions & Rankings of Rebrote Pharma
Contact details
Rebrote Pharma Private Limited's registered office is in Sreebhumi, West Bengal.
- Registered Address142 Canal Street, L.P.108/7/2, Sreebhumi, West Bengal, India – 700048
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Rebrote Pharma Private Limited
FY 2024 filings availableFinancial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Rebrote Pharma Private Limited, buy the company report.
Board of directors of Rebrote Pharma Private Limited
Rebrote Pharma has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Diwakar Kumar Agrawal | Director | 13 Nov 2022 | 3 Years 11 Months | Current |
| Puja Kumari Also directs: Manya Sarees Private Limited | Director | 13 Nov 2022 | 3 Years 11 Months | Current |
| Bhavana Jalan | Director | 08 May 2025 | 1 Years 5 Months | Current |
| Sandeep Jalan | Director | 08 May 2025 | 1 Years 5 Months | Current |
Legal cases
No court or tribunal cases involving Rebrote Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rebrote Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Rebrote Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rebrote Pharma Private Limited has 4 board changes on record since 2022: 4 appointments. The latest: Bhavana Jalan was appointed as Director on 08 May 2025.
Frequently asked questions
Rebrote Pharma is an active private limited company based in Sreebhumi, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 November 2022 (4+ years old) and is registered under CIN U52291WB2022PTC258188.
Rebrote Pharma has 4 current directors:
- Diwakar Kumar Agrawal - Director
- Puja Kumari - Director
- Bhavana Jalan - Director
- Sandeep Jalan - Director
The latest financial statements of Rebrote Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Rebrote Pharma is U52291WB2022PTC258188. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rebrote Pharma was incorporated on 13 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Kolkata.
Bhavana Jalan was appointed as Director on 08 May 2025. Sandeep Jalan was appointed as Director on 08 May 2025. Diwakar Kumar Agrawal was appointed as Director on 13 Nov 2022. Rebrote Pharma has 4 board changes on record in total.
Yes, Rebrote Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-08-0028991).
The registered office of Rebrote Pharma is at 142 Canal Street, L.P.10872, Sreebhumi, West Bengal, India – 700048.
Rebrote Pharma operates in the pharma industry, in the drug formulation and development segment.
Rebrote Pharma can be reached at its registered office: 142 Canal Street, L.P.10872, Sreebhumi, West Bengal, India – 700048.

